5-MAPB: Difference between revisions

(4 intermediate revisions by 2 users not shown)

Line 102:

*'''France''': 5-MAPB is classified as a narcotic since May 9, 2018, alongside other substances derived from benzofuran.<ref>{{cite web|url=https://www.legifrance.gouv.fr/loda/article_lc/LEGIARTI000043529751|title=Article Annexe IV - Arrêté du 22 février 1990 fixant la liste des substances classées comme stupéfiants|publisher=Légifrance|access-date=September 23, 2022|language=fr}}</ref>

*'''Germany''': 5-MAPB is controlled under the NpSG (New Psychoactive Substances Act)<ref>{{cite web|url=https://www.gesetze-im-internet.de/npsg/anlage.html|title=Anlage NpSG|publisher=Bundesministerium der Justiz und für Verbraucherschutz|access-date=December 18, 2019|language=de}}</ref> as of November 26, 2016.<ref>{{cite web|url=https://www.bgbl.de/xaver/bgbl/start.xav?startbk=Bundesanzeiger_BGBl&jumpTo=bgbl116s2615.pdf#__bgbl__%2F%2F*%5B%40attr_id%3D%27bgbl116s2615.pdf%27%5D__1576017393518|title=Gesetz zur Bekämpfung der Verbreitung neuer psychoaktiver Stoffe|publisher=Bundesanzeiger Verlag|access-date=December 18, 2019|language=de}}</ref> Production and import with the aim to place it on the market, administration to another person and trading is punishable. Possession is illegal but not penalized.<ref>{{cite web|url=https://www.gesetze-im-internet.de/npsg/__4.html|title=§ 4 NpSG|publisher=Bundesministerium der Justiz und für Verbraucherschutz|access-date=December 18, 2019|language=de}}</ref>

*'''Japan''': 5-MAPB is a controlled substance in Japan effective August 15th, 2015.<ref>[https://www.mhlw.go.jp/seisakunitsuite/bunya/kenkou_iryou/iyakuhin/yakubuturanyou/ihou-drug/20140815.html "平成26年8月15日付けで以下の21物質が指定薬物に指定されました。（施行日：平成26年8月25日）"] (in Japanese). 厚生労働省 [Ministry of Health, Labour and Welfare (MHLW)]. Retrieved on May 2, 2022.</ref>

*'''Luxembourg:''' 5-MAPB is not cited in the list of prohibited substances<ref>Loi du 19 février 1973 concernant la vente de substances médicamenteuses et la lutte contre la toxicomanie. | <nowiki>http://legilux.public.lu/eli/etat/leg/loi/1973/02/19/n1/jo</nowiki></ref>. Therefore, it is still a legal substance.

*'''Switzerland''': 5-MAPB is a controlled substance specifically named under Verzeichnis E.<ref>{{cite web|url=https://www.admin.ch/opc/de/classified-compilation/20101220/index.html|title=Verordnung des EDI über die Verzeichnisse der Betäubungsmittel, psychotropen Stoffe, Vorläuferstoffe und Hilfschemikalien|publisher=Bundeskanzlei [Federal Chancellery of Switzerland]|access-date=January 1, 2020|language=de}}</ref>

*'''United Kingdom''': 5-MAPB is a Class B drug.

*'''United Kingdom''': 5-MAPB is a Class B drug.<ref>UK Home Office (2014-03-05). "[https://www.legislation.gov.uk/ukdsi/2014/9780111110904 The Misuse of Drugs Act 1971 (Ketamine etc.) (Amendment) Order 2014]". UK Government. Retrieved 2014-03-11.</ref>

*'''United States''': 5-MAPB could be considered an analogue of [[MDA]] and therefore would be covered under the Federal Analogue Act if intended for human consumption.

@@ Line 102: / Line 102: @@
 {{legalStub}}
+*'''France''': 5-MAPB is classified as a narcotic since May 9, 2018, alongside other substances derived from benzofuran.<ref>{{cite web|url=https://www.legifrance.gouv.fr/loda/article_lc/LEGIARTI000043529751|title=Article Annexe IV - Arrêté du 22 février 1990 fixant la liste des substances classées comme stupéfiants|publisher=Légifrance|access-date=September 23, 2022|language=fr}}</ref>
 *'''Germany''': 5-MAPB is controlled under the NpSG (New Psychoactive Substances Act)<ref>{{cite web|url=https://www.gesetze-im-internet.de/npsg/anlage.html|title=Anlage NpSG|publisher=Bundesministerium der Justiz und für Verbraucherschutz|access-date=December 18, 2019|language=de}}</ref> as of November 26, 2016.<ref>{{cite web|url=https://www.bgbl.de/xaver/bgbl/start.xav?startbk=Bundesanzeiger_BGBl&jumpTo=bgbl116s2615.pdf#__bgbl__%2F%2F*%5B%40attr_id%3D%27bgbl116s2615.pdf%27%5D__1576017393518|title=Gesetz zur Bekämpfung der Verbreitung neuer psychoaktiver Stoffe|publisher=Bundesanzeiger Verlag|access-date=December 18, 2019|language=de}}</ref> Production and import with the aim to place it on the market, administration to another person and trading is punishable. Possession is illegal but not penalized.<ref>{{cite web|url=https://www.gesetze-im-internet.de/npsg/__4.html|title=§ 4 NpSG|publisher=Bundesministerium der Justiz und für Verbraucherschutz|access-date=December 18, 2019|language=de}}</ref>
 *'''Japan''': 5-MAPB is a controlled substance in Japan effective August 15th, 2015.<ref>[https://www.mhlw.go.jp/seisakunitsuite/bunya/kenkou_iryou/iyakuhin/yakubuturanyou/ihou-drug/20140815.html "平成26年8月15日付けで以下の21物質が指定薬物に指定されました。（施行日：平成26年8月25日）"] (in Japanese). 厚生労働省 [Ministry of Health, Labour and Welfare (MHLW)]. Retrieved on May 2, 2022.</ref>
 *'''Luxembourg:''' 5-MAPB is not cited in the list of prohibited substances<ref>Loi du 19 février 1973 concernant la vente de substances médicamenteuses et la lutte contre la toxicomanie. | <nowiki>http://legilux.public.lu/eli/etat/leg/loi/1973/02/19/n1/jo</nowiki></ref>. Therefore, it is still a legal substance.
 *'''Switzerland''': 5-MAPB is a controlled substance specifically named under Verzeichnis E.<ref>{{cite web|url=https://www.admin.ch/opc/de/classified-compilation/20101220/index.html|title=Verordnung des EDI über die Verzeichnisse der Betäubungsmittel, psychotropen Stoffe, Vorläuferstoffe und Hilfschemikalien|publisher=Bundeskanzlei [Federal Chancellery of Switzerland]|access-date=January 1, 2020|language=de}}</ref>
-*'''United Kingdom''': 5-MAPB is a Class B drug.
+*'''United Kingdom''': 5-MAPB is a Class B drug.<ref>UK Home Office (2014-03-05). "[https://www.legislation.gov.uk/ukdsi/2014/9780111110904 The Misuse of Drugs Act 1971 (Ketamine etc.) (Amendment) Order 2014]". UK Government. Retrieved 2014-03-11.</ref>
 *'''United States''': 5-MAPB could be considered an analogue of [[MDA]] and therefore would be covered under the Federal Analogue Act if intended for human consumption.